PANX1 and autoimmune disease: Recently, PBN has drawn interest as a candidate drug for repositioning for medical applications, including IBD, autoimmune diseases, neuroinflammation, and cardiovascular diseases, based on the finding that PBN inhibits pannexin-1 (Px1) channels [9,10,11,12].